1. Home
  2. PRM vs SUPN Comparison

PRM vs SUPN Comparison

Compare PRM & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRM
  • SUPN
  • Stock Information
  • Founded
  • PRM 2018
  • SUPN 2005
  • Country
  • PRM United States
  • SUPN United States
  • Employees
  • PRM N/A
  • SUPN N/A
  • Industry
  • PRM Newspapers/Magazines
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRM Consumer Discretionary
  • SUPN Health Care
  • Exchange
  • PRM Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • PRM 3.2B
  • SUPN 2.6B
  • IPO Year
  • PRM N/A
  • SUPN 2012
  • Fundamental
  • Price
  • PRM $23.51
  • SUPN $55.13
  • Analyst Decision
  • PRM Strong Buy
  • SUPN Strong Buy
  • Analyst Count
  • PRM 2
  • SUPN 4
  • Target Price
  • PRM $25.00
  • SUPN $63.25
  • AVG Volume (30 Days)
  • PRM 1.3M
  • SUPN 814.8K
  • Earning Date
  • PRM 10-30-2025
  • SUPN 11-04-2025
  • Dividend Yield
  • PRM N/A
  • SUPN N/A
  • EPS Growth
  • PRM N/A
  • SUPN 1411.53
  • EPS
  • PRM 0.52
  • SUPN 1.14
  • Revenue
  • PRM $636,343,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • PRM $1.84
  • SUPN $7.31
  • Revenue Next Year
  • PRM $6.07
  • SUPN $21.87
  • P/E Ratio
  • PRM $44.98
  • SUPN $48.19
  • Revenue Growth
  • PRM 19.12
  • SUPN 5.55
  • 52 Week Low
  • PRM $8.76
  • SUPN $29.16
  • 52 Week High
  • PRM $27.74
  • SUPN $57.65
  • Technical
  • Relative Strength Index (RSI)
  • PRM 56.77
  • SUPN 72.15
  • Support Level
  • PRM $21.00
  • SUPN $51.84
  • Resistance Level
  • PRM $27.74
  • SUPN $57.65
  • Average True Range (ATR)
  • PRM 1.50
  • SUPN 1.76
  • MACD
  • PRM 0.14
  • SUPN 0.40
  • Stochastic Oscillator
  • PRM 47.39
  • SUPN 73.94

About PRM Perimeter Solutions SA

Perimeter Solutions Inc is a solutions provider for the Fire Safety and Specialty Products industries. The Company's products and operations are managed and reported in two operating segments. Its Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services typically offered in conjunction with the Company's retardant and foam products. The Specialty Products segment includes operations that develop, produce and market products for non-fire safety markets. Specialty Products segment is Phosphorus Pentasulfide (P2S5) based lubricant additives. P2S5 is also used in pesticide and mining chemicals applications, and emerging electric battery technologies.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: